Hideaki Fujita Selected Research

Autosomal Recessive Polycystic Kidney (Polycystic Kidney Disease, Infantile, Type I)

10/2017

NEDD4-family E3 ligase dysfunction due to PKHD1/Pkhd1 defects suggests a mechanistic model for ARPKD pathobiology.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hideaki Fujita Research Topics

Disease

6	Infections 04/2024 - 11/2010
5	Vesicular Stomatitis 04/2024 - 12/2015
5	Neoplasms (Cancer) 01/2023 - 10/2013
2	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2020 - 12/2015
2	Breast Neoplasms (Breast Cancer) 01/2017 - 11/2008
2	Lung Neoplasms (Lung Cancer) 10/2013 - 05/2013
2	Experimental Melanoma 05/2011 - 06/2009
1	Wounds and Injuries (Trauma) 07/2023
1	Atopic Dermatitis (Atopic Eczema) 01/2023
1	Hypersensitivity (Allergy) 01/2022
1	Sick Building Syndrome 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Liver Neoplasms (Liver Cancer) 01/2021
1	Colonic Neoplasms (Colon Cancer) 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2020
1	Chronic Disease (Chronic Diseases) 11/2019
1	Type 2 Diabetes Mellitus (MODY) 11/2019
1	Autosomal Recessive Polycystic Kidney (Polycystic Kidney Disease, Infantile, Type I) 10/2017
1	Fibrosis (Cirrhosis) 10/2017
1	Hypertension (High Blood Pressure) 10/2017
1	Hypopigmentation (Hypomelanosis) 05/2011
1	Multiple Myeloma 06/2009
1	Lacunar Stroke 04/2003

Drug/Important Bio-Agent (IBA)

5	Glycoproteins (Glycoprotein)IBA 04/2024 - 12/2015
5	Proteins (Proteins, Gene)FDA Link 04/2024 - 11/2008
4	Antiviral Agents (Antivirals)IBA 04/2024 - 01/2019
3	Phosphotransferases (Kinase)IBA 01/2020 - 05/2013
2	Viral Envelope ProteinsIBA 04/2024 - 01/2022
2	Tyrosine (L-Tyrosine)FDA Link 04/2024 - 11/2020
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2022 - 10/2017
2	GlycosphingolipidsIBA 01/2020 - 12/2015
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2013 - 05/2013
2	Gefitinib (Iressa)FDA Link 10/2013 - 05/2013
2	Monophenol Monooxygenase (Tyrosinase)IBA 05/2011 - 06/2009
1	Immunoglobulin E (IgE)IBA 01/2023
1	Tumor Biomarkers (Tumor Markers)IBA 11/2022
1	CytokinesIBA 01/2022
1	dehydrocostus lactoneIBA 01/2021
1	costunolideIBA 01/2021
1	Caspase 3 (Caspase-3)IBA 01/2020
1	OligosaccharidesIBA 01/2020
1	globotrioseIBA 01/2020
1	MytiLec-1IBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020
1	SugarsIBA 01/2020
1	p38 Mitogen-Activated Protein KinasesIBA 01/2020
1	SodiumIBA 10/2017
1	Antineoplastic Agents (Antineoplastics)IBA 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	Polysaccharides (Glycans)IBA 12/2015
1	CaspasesIBA 12/2015
1	LectinsIBA 12/2015
1	Death Domain ReceptorsIBA 12/2015
1	IntegrinsIBA 10/2013
1	ErbB Receptors (EGF Receptor)IBA 10/2013
1	((3Z)- N- (3- chlorophenyl)- 3- ((3,5- dimethyl- 4- ((4- methylpiperazin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- N- methyl- 2- oxo- 2,3- dihydro- 1H- indole- 5- sulfonamide)IBA 05/2013
1	Indicators and Reagents (Reagents)IBA 05/2011
1	16- hydroxy- 9- oxo- 10,12,14- octadecatrienoic acidIBA 05/2011
1	Ethanol (Ethyl Alcohol)IBA 05/2011
1	Cytidine DeaminaseIBA 11/2010
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 06/2009
1	Melanins (Melanin)IBA 06/2009
1	2'-hydroxy-2,4,4,7,4'-pentamethylflavanIBA 06/2009
1	acetylleucyl-leucyl-norleucinalIBA 11/2008
1	Proteasome Endopeptidase Complex (Proteasome)IBA 11/2008
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 11/2008
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 04/2003

Therapy/Procedure

2	Therapeutics 01/2023 - 01/2021
1	Air Bags (Airbags) 07/2023
1	Diet Therapy (Therapy, Diet) 11/2019
1	Drug Therapy (Chemotherapy) 01/2017